Effects of vasoconstrictors used in local anesthesia upon isolated rat heart

Pharmacological Research

Volumn 46, Issue 1, 2002, Pages 15-18

  Oliveira, N S ^a   Gazola, R ^a   Singi, G ^a  

^a School of Dentistry and Pharmacy   (Brazil)

Author keywords

Epinephrine; Felypressin; Isolated rat heart

Indexed keywords

ADRENALIN; FELYPRESSIN; VASOCONSTRICTOR AGENT;

ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; HEART CONTRACTION; HEART RATE; ISOLATED HEART; LOCAL ANESTHESIA; NONHUMAN; PRIORITY JOURNAL; RAT;

EID: 0036421524     PISSN: 10436618     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-6618(02)00074-9     Document Type: Article

References (15)

1. Neder AC, Garllip OF, Arruda JV. Estudos experimentais e clínicos do citanest com octapressin, nas anestesias parciais. Revista da Associação Paulista de Cirurgiões-dentistas 1974; 28: 228-30.
2. Dreyer AC, Offermeier J. The influence of desipramine on the blood pressure elevation and heart rate stimulation by levonordefrin and felypressin alone and in the presence of local anaesthetics. J Dental Assoc South Africa 1986; 41: 615-8.
3. Graf BM, Fischer B, Martin EO, Bonsjak ZJ, Stowe DF. Differential effects of arginine vasopressin on isolated guinea pig heart function during perfusion at constant flow and constant pressure. J Cardiovascular Pharmacol 1997; 29: 1-7.
4. Aellig WH, Laurence DR, O'neil R, Verril PJ. Cardiac effects of adrenaline and felypressin as vasoconstrictors in local anaesthetics for oral surgery under diazepam sedation. Br J Anaesth 1970; 42: 174-6.
5. Akerman B. On felypressin (Octapressin®) as an adjunct to lidocaine and prilocaine - An experimental study in animals. Acta Pharmacol Toxicol 1966; 24: 377-88.
6. Oliveira MAM, Tortamano N, Armonia PL, Rocha RG. Estudo comparativo dos efeitos da lidocaína com noradrenalina e da prilocaína com felipressina sobre o sistema cardiovascular, em cães, em decorrência da variação da dose, via e tempo de administração. Revista da Faculdade de Odontologia de São Paulo 1986; 21: 75-92.
7. Frost BR, Gerke DC, Frewin DB. The effects of 2-phenylalanine-8-lysine vasopressin (Octapressin®) on blood vessels in the rat tail. Austr J Exp Biol Med Sci 1976; 54: 403-11.
8. Gerke DC, Halloran TN, Frewin DB. The use of mixtures of octapressin® and adrenaline in local anaesthetic solutions to obtain more effective vasoconstriction. Austr Dental J 1978; 23: 240-3.
9. Singi G, Caram MM, Teixeira VE, Moreira LA. Indicação do uso de felipressina (Octapressin®) como vasoconstritor nas anestesias locais. Revista Brasileira de Medicina 1996; 53: 597-604.
10. Maxwell GM. The cardiovascular effects of octapressin. Archives Internationales de Pharmacodynamie et de Therapie 1965; 158: 17-23.
11. 2+]i and protein kinase C invasopressin-induced prostacyclin and ANP release in rat cardiomyocytes. Am J Physiol 1994; 266: H597-605.
12. Altura BM, Hershei SG, Zweifach BW. Effects of a synthetic analogue vasopressin on vascular smooth muscle. Proc Soc Exp Biol Med 1965; 119: 258-61.
13. Singi G, Caram MM, Moreira LA, Jorge MHB. Verificação dos efeitos da associação adrenalina + felipressina em coração isolado de cobaio. Revista Brasileira de Medicina 1998; 55: 693-700.
14. Agata H, Ichinohe T, Kaneko Y. Felypressin-induced reduction in coronary blood flow and myocardial tissue oxygen tension during anesthesia in dogs. Can J Anaesthesiol 1999; 46: 1070-5.
15. Wilson MF, Brackett DJ, Archer LT, Hinshaw LB. Mechanisms of impaired cardiac function by vasopressin. Ann Surg 1980; 191: 494-500.